Goldman Sachs
SPPI

Goldman Sachs’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Goldman Sachs’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-19,106
Closed -$18.3K – 6048
2023
Q2 		$18.3K Sell
19,106
-320
-2% -$316 ﹤0.01% 5557
2023
Q1 		$14.6K Buy
19,426
+6,495
+50% +$4.74K ﹤0.01% 5701
2022
Q4 		$4.76K Sell
12,931
-71,894
-85% -$30.3K ﹤0.01% 5817
2022
Q3 		$37K Sell
84,825
-191,338
-69% -$188K ﹤0.01% 5834
2022
Q2 		$215K Buy
276,163
+28,092
+11% +$24.8K ﹤0.01% 5613
2022
Q1 		$320K Sell
248,071
-2,668,648
-91% -$2.46M ﹤0.01% 5625
2021
Q4 		$3.71M Buy
2,916,719
+2,518,287
+632% +$4.5M ﹤0.01% 3705
2021
Q3 		$868K Buy
398,432
+4,788
+1% +$13.1K ﹤0.01% 4858
2021
Q2 		$1.48M Sell
393,644
-37,446
-9% -$130K ﹤0.01% 4466
2021
Q1 		$1.41M Sell
431,090
-285,913
-40% -$1.02M ﹤0.01% 4333
2020
Q4 		$2.44M Sell
717,003
-9,442
-1% -$38.9K ﹤0.01% 3575
2020
Q3 		$2.96M Sell
726,445
-123,858
-15% -$471K ﹤0.01% 3293
2020
Q2 		$2.87M Sell
850,303
-257,037
-23% -$749K ﹤0.01% 3202
2020
Q1 		$2.58M Buy
1,107,340
+392,619
+55% +$1.07M ﹤0.01% 3124
2019
Q4 		$2.6M Buy
714,721
+295,196
+70% +$2.39M ﹤0.01% 3463
2019
Q3 		$3.48M Sell
419,525
-58,438
-12% -$473K ﹤0.01% 3126
2019
Q2 		$4.12M Sell
477,963
-210,155
-31% -$1.88M ﹤0.01% 2984
2019
Q1 		$7.36M Sell
688,118
-70,545
-9% -$755K ﹤0.01% 2676
2018
Q4 		$6.64M Buy
758,663
+151,251
+25% +$1.93M ﹤0.01% 2656
2018
Q3 		$10.2M Buy
607,412
+148,611
+32% +$3.22M ﹤0.01% 2443
2018
Q2 		$9.62M Sell
458,801
-1,382,938
-75% -$25.6M ﹤0.01% 2438
2018
Q1 		$29.6M Sell
1,841,739
-15,841
-0.9% -$314K 0.01% 1533
2017
Q4 		$35.2M Buy
1,857,580
+42,629
+2% +$772K 0.01% 1534
2017
Q3 		$25.5M Buy
1,814,951
+557,993
+44% +$5.05M 0.01% 1792
2017
Q2 		$9.36M Sell
1,256,958
-370,186
-23% -$2.42M ﹤0.01% 2557
2017
Q1 		$10.6M Sell
1,627,144
-102,689
-6% -$574K ﹤0.01% 2369
2016
Q4 		$7.66M Buy
1,729,833
+84,790
+5% +$356K ﹤0.01% 2669
2016
Q3 		$7.68M Buy
1,645,043
+77,848
+5% +$461K ﹤0.01% 2670
2016
Q2 		$10.3M Buy
1,567,195
+109,338
+7% +$773K ﹤0.01% 2299
2016
Q1 		$9.27M Buy
1,457,857
+91,447
+7% +$469K ﹤0.01% 2282
2015
Q4 		$8.24M Buy
1,366,410
+13,889
+1% +$79.4K ﹤0.01% 2404
2015
Q3 		$8.09M Sell
1,352,521
-168,763
-11% -$1.17M ﹤0.01% 2425
2015
Q2 		$10.4M Sell
1,521,284
-41,039
-3% -$261K ﹤0.01% 2304
2015
Q1 		$9.48M Buy
1,562,323
+282,930
+22% +$1.88M ﹤0.01% 2338
2014
Q4 		$8.87M Buy
1,279,393
+809
+0.1% +$5.95K ﹤0.01% 2457
2014
Q3 		$10.4M Buy
1,278,584
+55,263
+5% +$432K ﹤0.01% 2325
2014
Q2 		$9.95M Sell
1,223,321
-162,452
-12% -$1.23M ﹤0.01% 2372
2014
Q1 		$10.9M Buy
1,385,773
+58,213
+4% +$493K ﹤0.01% 2299
2013
Q4 		$11.7M Buy
1,327,560
+56,050
+4% +$501K ﹤0.01% 2226
2013
Q3 		$10.7M Sell
1,271,510
-17,092
-1% -$138K ﹤0.01% 2184
2013
Q2 		$9.61M Buy
+1,288,602
New +$9.89M ﹤0.01% 2132

Goldman Sachs's SPPI Position: Q3 2023 in Review

Goldman Sachs sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 19,106 shares — an estimated $18.3K sold.

Goldman Sachs first reported a position in SPPI in Q2 2013 and held it in 41 quarters. The position peaked at $35.2M in Q4 2017. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.

  • Goldman Sachs reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
  • Goldman Sachs sold 19,106 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $18.3K.
  • Goldman Sachs first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 41 quarters.
  • Goldman Sachs's Spectrum Pharmaceuticals Inc position peaked at $35.2M in Q4 2017.
  • 0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.

Based on Goldman Sachs's 13F filing for Q3 2023, filed 14 Nov 2023.